581
Views
22
Crossref
N/A
WoS
19
Scopus
6
CSCD
Immunotherapy, a burgeoning field differs from traditional cancer treatments, is revolutionizing oncologic therapeutics. It aims to stimulate the innate and adaptive immune system of a patient to fight against tumor cells. However, low response rate and immune-related adverse effects (irAEs) remain problems during its management. A novel technology using nanomaterials may bring a solution. Various nanoparticles have been investigated as delivery systems to augment cancer therapeutic efficacy in the lab and clinic. In this review, we briefly summarize the connotation of immunotherapy, the application of nanotechnology in cancer, especially focusing on the synergistic effect of nanoplatform-based technology combined with cancer immunotherapy, hoping to make readers a deep insight into this interdisciplinary field.
This work was supported by the National Natural Science Foundation of China (Nos. 81860547, 81573008, 21671150, 21877084, 81171646, 31170776, and 21472139), the Science and Technology Commission of Shanghai Municipality (Nos. 14DZ2261100 and 15DZ1940106), the Fundamental Research Funds for the Central Universities (No. kx0150720173382) and the Joint Project of Health and Family Planning Committee of Pudong New Area (No. PW2017D-10).